Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Ask A Doctor: Do You Still Need the Vaccine If You've Already Had COVID-19?

By Keith Speights - Dec 20, 2020 at 11:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There's a clear answer to that question.

Pfizer ( PFE -1.24% ) won emergency use authorization (EUA) for its COVID-19 vaccine late last week. Some Americans have already received the vaccine with many others awaiting the delivery of more doses. But do individuals who have already had COVID-19 still need to be vaccinated? In this Motley Fool Live video recorded on Dec. 11, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina talked with immunotherapy scientist Dr. Leo Nissola about this important question.

Corrine Cardina: I actually saved a viewer question for you that has to do with this herd immunity issue. Steve would like to know, "If you already had the virus, do you still need the vaccine?"

Has there been any guidance on that? Because it's not an insignificant number of the population who have been infected and recovered, and they are wondering, should they get vaccinated?

Dr. Leo Nissola: Steve has a very good question. So thank you for asking.

I've been getting that question lately by the dozens and the answer is yes. If you have had COVID-19 and you've developed antibodies, you do not want to spend your lifetime checking to see if your natural antibodies are still there. You do not want to have to worry about winning off of those antibodies, if that's even possible.

Right now, currently, the discussions around vaccination campaigns and plans, which we have not seen from the federal government yet a robust vaccination plan. I hope that president-elect Joe Biden will implement those changes in the future, is that we actually encouraged people to get the vaccine even though they may have had COVID in the past.

Corrine Cardina: Great answer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$54.00 (-1.24%) $0.68

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
635%
 
S&P 500 Returns
141%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/02/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.